Overexpressed TP53INP2 is found to suppress the activity, migration, and invasion of ccRCC cells, thereby inhibiting tumor growth in mice and promoting cell apoptosis. This evidence concerns the gene TP53INP2 and nonpapillary renal cell carcinoma.